|
|
|
Insider
Information: |
Satter Muneer A |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
60,789,542 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$72,418,216 |
|
|
Total
Shares |
60,789,542 |
|
|
Total
Value |
$72,418,216 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
DFC Global Corp |
DLLR |
Director |
|
0 |
2005-01-27 |
1,193,504 |
Premium* |
|
HeartWare International Inc |
HTWR |
10% Owner |
2008-04-14 |
0 |
2008-07-11 |
25,150,000 |
Premium* |
|
Akebia Therapeutics, Inc. |
AKBA |
Director |
2014-03-25 |
0 |
2017-07-05 |
3,037,042 |
Premium* |
|
Immunic Inc |
IMUX |
Director, 10% Owner |
|
0 |
2018-09-17 |
0 |
Premium* |
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
10% Owner |
2014-09-22 |
0 |
2014-09-22 |
1,771,688 |
Premium* |
|
Aadi Bioscience, Inc |
AADI |
Director, 10% Owner |
2017-03-15 |
0 |
2019-01-10 |
5,621,835 |
Premium* |
|
Aileron Therapeutics Inc |
ALRN |
See Remarks, Director |
2017-07-05 |
0 |
2021-01-08 |
16,609,449 |
Premium* |
|
Annexon, Inc. |
ANNX |
Director, 10% Owner |
2020-07-28 |
0 |
2023-12-26 |
7,406,024 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AADI |
Aadi Bioscience, Inc |
Director |
|
2017-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,121,835 |
|
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2017-03-15 |
4 |
B |
$5.00 |
$5,600,000 |
I/I |
1,120,000 |
3,241,835 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-03-19 |
4 |
B |
$4.96 |
$37,725 |
I/I |
7,600 |
3,249,435 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-03-20 |
4 |
B |
$4.97 |
$26,860 |
I/I |
5,400 |
3,254,835 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-03-21 |
4 |
B |
$4.85 |
$19,390 |
I/I |
4,000 |
3,258,835 |
2.17 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-03-23 |
4 |
B |
$5.00 |
$5,000 |
I/I |
1,000 |
3,259,835 |
2.17 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-06-28 |
4 |
B |
$3.85 |
$7,000,001 |
I/I |
1,818,182 |
5,078,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-11-28 |
4 |
B |
$1.94 |
$38,714 |
I/I |
20,000 |
5,098,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-11-29 |
4 |
B |
$2.01 |
$40,118 |
I/I |
20,000 |
5,118,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-11-30 |
4 |
B |
$1.98 |
$39,692 |
I/I |
20,000 |
5,138,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-03 |
4 |
B |
$1.99 |
$39,774 |
I/I |
20,000 |
5,158,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-04 |
4 |
B |
$2.10 |
$41,994 |
I/I |
20,000 |
5,178,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-06 |
4 |
B |
$2.18 |
$43,584 |
I/I |
20,000 |
5,198,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-07 |
4 |
B |
$2.14 |
$42,788 |
I/I |
20,000 |
5,218,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-10 |
4 |
B |
$2.13 |
$42,608 |
I/I |
20,000 |
5,238,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-11 |
4 |
B |
$2.09 |
$41,846 |
I/I |
20,000 |
5,258,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-12 |
4 |
B |
$2.05 |
$40,938 |
I/I |
20,000 |
5,278,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-13 |
4 |
B |
$2.02 |
$40,308 |
I/I |
20,000 |
5,298,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-14 |
4 |
B |
$2.00 |
$40,094 |
I/I |
20,000 |
5,318,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-18 |
4 |
B |
$1.99 |
$39,856 |
I/I |
20,000 |
5,338,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-19 |
4 |
B |
$1.92 |
$38,384 |
I/I |
20,000 |
5,358,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-20 |
4 |
B |
$1.85 |
$36,984 |
I/I |
20,000 |
5,378,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-21 |
4 |
B |
$1.84 |
$36,870 |
I/I |
20,000 |
5,398,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-26 |
4 |
B |
$1.69 |
$33,854 |
I/I |
20,000 |
5,418,017 |
2.25 |
- |
|
AADI |
Aadi Bioscience, Inc |
Director |
|
2018-12-27 |
4 |
B |
$1.67 |
$33,410 |
I/I |
20,000 |
5,438,017 |
2.25 |
- |
|
91 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|